FDA advisers dismiss safety warnings, back four peptide treatments

MedicalXpress | 七月 24, 2026

A panel of outside advisers to the U.S. Food and Drug Administration (FDA) voted Thursday to let specialized pharmacies produce and sell four peptide treatments the agency banned three years ago.